The Food and Drug Administration (FDA) announces the approval of Dengvaxia, the first vaccine approved for the prevention of dengue disease caused by all dengue virus serotypes (1, 2, 3 and 4) in people ages 9 through 16 who have laboratory-confirmed previous dengue infection and who live in ende
Millions of people are infected with hepatitis B every year. Hundreds of thousands die. And small children are particularly at risk.
Penn Medicine (in Philadelphia) has won ECRI Institute’s 2019 Health Devices Achievement Award for developing an app that enables patients to wean off ventilators faster.
In late March 2019, the World Health Organization and a vaccine advisory committee of the Food and Drug Administration selected the final influenza strains to include in the vaccines produced for the next flu season. These include H1N1, influenza B, and H3N2 viruses.
A new study examines the barriers to vaccination of immunocompromised children (ICC). Findings from the study will be presented during the Pediatric Academic Societies (PAS) 2019 Meeting, taking place on April 24 through May 1 in Baltimore.
Text message reminders led to timely HPV vaccine series completion across a low-income, urban, minority population, according to a new study.
Despite the increasing trends in uptake, the human papillomavirus (HPV) vaccine coverage is far behind other infant vaccines in many states, according to a new study, which describes the trends in HPV vaccine uptake in children in the U.S.
Pediatricians and nurse practitioners report using several strategies to improve human papillomavirus (HPV) vaccination, yet also perceive barriers, according to a national American Academy of Pediatrics (AAP) Pediatric Research in Office Settings (PROS) network study.
A new systematic review provides a succinct summary of the scientific evidence for and/or against causal associations for 47 adverse events following immunization (AEFI).
Exploring the importance of disinfecting non-critical and environmental surfaces.